Patent No. EP4253558 (titled "Identification And Use Of Circulating Nucleic Acid Tumor Markers") was filed by The Board OF Trustees OF The Leland Stanford Junior University on Mar 12, 2014. The application was issued on Jul 2, 2025.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents